Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Renan Canibal Pires"'
Autor:
Lisiane Smiderle, Luciana O. Lima, Mara Helena Hutz, Cézar Roberto Van der Sand, Luiz Carlos Van der Sand, Maria Elvira Wagner Ferreira, Renan Canibal Pires, Silvana Almeida, Marilu Fiegenbaum
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 103, Iss 1, Pp 33-40 (2014)
Background: Dyslipidemia is the primary risk factor for cardiovascular disease, and statins have been effective in controlling lipid levels. Sex differences in the pharmacokinetics and pharmacodynamics of statins contribute to interindividual variati
Externí odkaz:
https://doaj.org/article/8503df63ee834ae2acea732a17c90c82
Autor:
João Carlos Vieira da Costa Guaragna, Valério Martins, Tatiana Marlowe Cunha Brunini, José Luis Linhatti, Fábio Branco de Araújo Brauner, Renan Canibal Pires, Luiz Carlos Bodanese
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 69, Iss 6, Pp 401-405 (1997)
OBJETIVO: Relatar a experiência no emprego de altas doses de amiodarona via oral (1800mg/d) na reversão da fibrilação atrial (FA) em pacientes submetidos à cirurgia cardíaca. MÉTODOS: Analisados, retrospectivamente, 80 pacientes que apresentar
Externí odkaz:
https://doaj.org/article/20d4a6af8c39482692bdb97843cd4d83
Autor:
Maria Elvira Wagner Ferreira, Renan Canibal Pires, Silvana Almeida, Luciana O. Lima, Marilu Fiegenbaum, Cézar Roberto Van der Sand, Mara H. Hutz, Estela M. Bruxel, Luiz Carlos Van der Sand
Publikováno v:
Arquivos Brasileiros de Endocrinologia & Metabologia v.57 n.7 2013
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 57, Issue: 7, Pages: 513-519, Published: OCT 2013
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 57, Issue: 7, Pages: 513-519, Published: OCT 2013
OBJECTIVE: The aim of the present study was investigate the association between six genetic variants in the nuclear receptor genes PPARA, RXRA, NR1I2 and NR1I3 and the lipid-lowering efficacy and safety of statin therapy. SUBJECTS AND METHODS: The st
Autor:
Maria Elvira Wagner Ferreira, Marilu Fiegenbaum, L C Van der Sand, Renan Canibal Pires, C R Van der Sand, Silvana Almeida, Lisiane Smiderle, Mara H. Hutz
Publikováno v:
Europe PubMed Central
Lipid-lowering therapy has shown a high degree of variability in clinical response and there is evidence that the variability in drug response between individuals is due to genetic factors. Thirteen single nucleotide polymorphisms (SNPs) within the E
Autor:
Maria Elvira Wagner Ferreira, Renan Canibal Pires, Jéssica Aguiar de Souza, Luciana O. Lima, Luiz Carlos Van der Sand, Cézar Roberto Van der Sand, Angelica Menin, Marilu Fiegenbaum, Mara H. Hutz, Silvana Almeida, Lisiane Smiderle
Publikováno v:
Clinical biochemistry. 48(16-17)
Objectives PON1 plays an important role in inhibiting LDL-C oxidation, which reduces atherosclerosis and cardiovascular disease. Elevated PON1 activity or levels may contribute to increased HDL-C levels, but controversy exists over the hypothesis tha
Autor:
Marilu Fiegenbaum, Cézar Roberto Van der Sand, Renan Canibal Pires, Maria Elvira Wagner Ferreira, Fabiano Roldao Silveira, Luiz Carlos Van der Sand, Mara H. Hutz
Publikováno v:
Clinica Chimica Acta. 362:182-188
Background In recent years, one of the focuses of genetic investigation in cardiology has been to identify the genetic factors associated with variable response to statin treatment. Polymorphisms in apolipoprotein E (APOE), cholesteryl ester transfer
Autor:
Renan Canibal Pires, Mara H. Hutz, Maria Elvira Wagner Ferreira, Luiz Carlos Van der Sand, Fabiano Roldao Silveira, Cézar Roberto Van der Sand, Marilu Fiegenbaum
Publikováno v:
Clinical Pharmacology & Therapeutics. 78:551-558
Our objective was to investigate the interactions between common polymorphisms in ABCB1, CYP3A4, and CYP3A5 genes and the lipid-lowering efficacy and safety of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin.One hundred sixt
Autor:
Renan Canibal Pires, Maria Elvira Wagner Ferreira, Fabiano Roldao Silveira, Mara H. Hutz, L C Van der Sand, Marilu Fiegenbaum, C R Van der Sand
Publikováno v:
The Pharmacogenomics Journal. 5:359-364
We investigated the effect of single-nucleotide polymorphisms in sterol regulatory element-binding factors-1a and -2 (SREBF-1a and SREBF-2) and SREBF cleavage-activating protein (SCAP) genes on lipid-lowering response to simvastatin. In all, 146 hype
Autor:
Marilu Fiegenbaum, Silvana Almeida, Renan Canibal Pires, Luciana O. Lima, Luiz Carlos Van der Sand, Cézar Roberto Van der Sand, Maria Elvira Wagner Ferreira, Mara H. Hutz, Lisiane Smiderle
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 103, Iss 1, Pp 33-40 (2014)
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.103 n.1 2014
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.103 n.1 2014
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Background: Dyslipidemia is the primary risk factor for cardiovascular disease, and statins have been effective in controlling lipid levels. Sex differences in the pharmacokinetics and pharmacodynamics of statins contribute to interindividual variati
Autor:
Valério Martins, Luiz Carlos Bodanese, Renan Canibal Pires, Fábio Branco de Araújo Brauner, Tatiana Marlowe Cunha Brunini, José Luis Linhatti, João Carlos Vieira da Costa Guaragna
Publikováno v:
Arquivos Brasileiros de Cardiologia v.69 n.6 1997
Arquivos Brasileiros de Cardiologia
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 69, Issue: 6, Pages: 401-405, Published: DEC 1997
Arquivos Brasileiros de Cardiologia
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 69, Issue: 6, Pages: 401-405, Published: DEC 1997
OBJETIVO: Relatar a experiência no emprego de altas doses de amiodarona via oral (1800mg/d) na reversão da fibrilação atrial (FA) em pacientes submetidos à cirurgia cardíaca. MÉTODOS: Analisados, retrospectivamente, 80 pacientes que apresentar